Therefore, in addition to CD8+ cell depletion inhibiting the tumor immune response, immunotherapy induces a significant increase in tumor-associated fibroblasts, forming a spatial immune barrier to impede T cell infiltration. This evidence concerns the gene CD8A and neoplasm.